You are here: Industry Insights > Shares

News List

Laurus Labs promoters sell 52 lakh equity shares at aggregate Rs 191.67 crores expresspharma
March 05, 2021
Significant part of the above amount shall be utilised to release the pledge on their equity shares of the company.
Ortho Clinical Diagnostics Announces Pricing of Initial Public Offering prnasia
January 28, 2021
Ortho Clinical Diagnostics Holdings plc today announced the pricing of its initial public offering of 76 million ordinary shares at $17.00 per share.
Elekta divests its stake in ViewRay prnasia
January 22, 2021
Elekta AB (EKTA-B.ST) announced today that it has sold its 7.3 percent of the outstanding common stock (11,501,597 shares) in ViewRay, Inc. Elekta has no remaining shares in ViewRay after the transaction.
Sun Pharma board approves Rs 1,700 cr share buy-back offer expresspharma
March 19, 2020
Drug major Sun Pharmaceutical Industries said its board has approved Rs 1,700 crore share buyback offer at a maximum price of Rs 425 per share。
Alembic Pharma’s approves NCDs up to Rs 300 crore expressbpd
June 14, 2019
The company, which did not specify the reasons for raising funds, said it will issue NCDs in one or more tranches
DBV Technologies Announces the Launch of a Proposed Global Offering of Ordinary Shares, Which May Be in the Form of American Depositary Shares firstwordpharma
April 04, 2019
Goldman Sachs & Co. LLC and Citigroup are acting as joint lead book-running managers for the global offering. H.C. Wainwright & Co……
Motif Bio raises £2.7 million via share placing pharmatimes
March 27, 2019
Motif Bio has announced that it has raised £2.7 million from a share placing, to provide additional working capital.
Shares in Proteostasis Therapeutics plunge on disappointing results for cystic fibrosis triplet therapy firstwordpharma
March 26, 2019
Proteostasis Therapeutics' stock dropped as much as 63 percent Monday after the company reported disappointing results regarding the effect……
Editas Medicine shares fall over 20 percent on departure of CEO firstwordpharma
January 23, 2019
Editas Medicine said Tuesday that CEO Katrine Bosley has decided to step down from her role effective March 1, with board member Cynthia Collins appointed to the position on an interim basis.
Why Amarin's Latest News Caused Shares to Crash 13% Today fool
November 28, 2018
After the company announced a $200 million secondary offering of its American Depository Shares (ADS), Amarin Corporation plc (NASDAQ:AMRN) shares tumbled 13% on Tuesday......

Previous page 1 2 Next page